Pilot Study on Weight Loss in Guinea Bissau

Sponsor
Tufts University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03316742
Collaborator
USDA Human Nutrition Research Center on Aging (U.S. Fed)
0
1
2
1
0

Study Details

Study Description

Brief Summary

The purpose of this study is to test two versions a weight loss program potentially suitable for implementation in Africa. A successful method would have widespread application in low-income countries, with the potential to improve world health.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Intervention 1
  • Combination Product: Intervention 2
N/A

Detailed Description

Specific Aim 1 is to conduct a 3-4 month pilot study randomizing participants to two versions of a weight loss program. The program will be implemented in a convenience sample of overweight and obese adults living in Guinea-Bissau and measure changes in body weight loss (primary outcome), adherence to program recommendations including recommended food patterns, blood pressure, eating behavior, physical activity and mood (secondary outcomes). The data will be used to refine the weight loss program and conduct power calculations for a future trial.

Specific Aim 2 is to analyze associations between weight loss, participant demographics and program metrics, to explore reasons for differences in weight loss between participants. Factors to be tested include participant BMI, gender and age, as well as adherence to meal portion recommendations, use of sugar-sweetened beverages and provided foods, and physical activity.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Pilot Study on Weight Loss in Guinea Bissau
Anticipated Study Start Date :
Dec 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Jan 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention 1

Participants randomized to intervention 1 will complete baseline and endline outcomes and participate in version 1 of a weight loss program. Each participant will attend twelve one hour classes discussing weight loss adherence in addition to barriers experienced. Changes in weight will be recorded throughout the study.

Combination Product: Intervention 1
Intervention 1 includes providing participants with a high fiber food product, protein source, high intensity sweetener and adult multivitamin.

Experimental: Intervention 2

Participants randomized to intervention 2 will complete baseline and endline outcomes and participate in version 2 of a weight loss program. Each participant will attend 12 one hour classes discussing weight loss adherence in addition to barriers experienced. Changes in weight will be recorded throughout the study.

Combination Product: Intervention 2
Intervention 2 includes providing participants with an alternative dietary fiber source, milk protein, high intensitysweetener and adult multivitamin.

Outcome Measures

Primary Outcome Measures

  1. Change in weight [Week 1 - week 12]

    Primary outcome is weight change between baseline and endline.

Secondary Outcome Measures

  1. Intervention Adherence [week 1 - week 12]

    Adherence to the designated intervention will be measured by self-reported dietary intake.

  2. Change in Blood Pressure [baseline, week 12]

    A secondary outcome is change in blood pressure between baseline and endline.

  3. Change in self-reported measures of eating behavior. [baseline, week 12]

    Self-administered "Three Factor Eating Questionnaire" will be used to capture participants eating behavior between baseline and endline.

  4. Change in self-reported measures of mood. [baseline, week 12]

    Self-administered "Profile of Mood States Questionnaire" will be used to capture participants mood between baseline and endline.

  5. Change in self-reported measures of physical activity. [baseline, week 12]

    Self-administered "International Physical Activity Questionnaire" will be used to capture participants physical activity between baseline and endline.

  6. Change in self-reported demographics [baseline, week 12]

    A self administered demographics survey measures education, occupation, dietary food frequency and food security.

  7. Change in Height [Week 1, week 12]

    A secondary outcome is change in height between baseline and endline.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Men and women who are overweight or obese (BMI ≥25 kg/m2).

  • Want to lose weight, want to enroll in the study and are willing to sign the informed consent form.

  • Anticipate being able to meet the study requirements for food habits and study meetings, and anticipate remaining in Bissau for the study duration.

  • Between the ages of 20 to 65 years.

  • Non-pregnant women, and those who do not intend on becoming pregnant during the course of the study.

  • A doctor or nurse has signed a note approving participant in the weight loss intervention after seeing a copy of the handout with title "Instructions for Bissau Weight Loss Pilot Project", and a copy of his/her approval is given to the research staff.

Exclusion Criteria:
  • Report food allergies or intolerance or health conditions that would prevent consumption of provided and recommended foods.

  • Participation in another concurrent nutrition research study.

  • If premenopausal (<55 years of age), they are pregnant or intend to become pregnant during the course of the study, or are not using a birth control method to prevent pregnancy.

Contacts and Locations

Locations

Site City State Country Postal Code
1 International Partnership for Health Development Bissau Guinea-Bissau 1000

Sponsors and Collaborators

  • Tufts University
  • USDA Human Nutrition Research Center on Aging

Investigators

  • Principal Investigator: Susan B Roberts, PhD, Tufts University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Susan Roberts, Director and Senior Scientist, Tufts University
ClinicalTrials.gov Identifier:
NCT03316742
Other Study ID Numbers:
  • 12377
First Posted:
Oct 20, 2017
Last Update Posted:
Feb 23, 2022
Last Verified:
Feb 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Susan Roberts, Director and Senior Scientist, Tufts University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 23, 2022